Skip to main content
Clinical Trials/CTRI/2018/08/015445
CTRI/2018/08/015445Not yet recruitingPhase 2

Clinical Validation of Unani Pharmacopoeal formulation Laooq Khayar Shambar in Nazla (Common Cold)

Central Council For Research In Unani Medicine0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients of either sex in the age group of 18-65
  • 2. Patients of Nazla (Common Cold) presenting with recent onset of any of the following symptoms:
  • (i) KhushÅ«na al-Halaq (Sore Throat)
  • (ii) Buhha al-Sawt Hoarseness / Change of Voice
  • (iii)â??UtÄ?s â??Sneezing/ Nasal irritation
  • (iv)Rhinorrhoea/Runny nose
  • (v)SudÄ?â?? Headache
  • (vi)Suâ??Ä?l Cough
  • (vii)Iâ??yÄ? Malaise
  • (viii)Low grade fever (100 - 101°F)

Exclusion Criteria

  • Any one of the following:
  • 1. Patients of acute or chronic lower respiratory tract infection like pneumonia, Bronchitis, Asthma and Bronchiectasis.
  • 2. High Grade Fever > 101oF
  • 3. History of hepatic, renal disorders, diabetes mellitus, hypertension, anaemia, COPD or any other ailment requiring long term therapy
  • 4. Known cases of any other acute illness
  • 5. Pregnant and lactating women

Investigators

Similar Trials